Gonadotropin releasing hormone (GnRH) analogs for the treatment of breast and prostatic carcinoma Richard J. SantenAndrea ManniHarold Harvey Eighth San Antonio Breast Cancer Symposium Pages: 129 - 145
Tumor nuclear grade, estrogen receptor, and progesterone receptor: Their value alone or in combination as indicators of outcome following adjuvant therapy for breast cancer Bernard FisherEdwin R. FisherContributing NSABP Investigators Report Pages: 147 - 160
Prognostic implication of labeling index versus estrogen receptors and tumor size in node-negative breast cancer Rosella SilvestriniMaria Grazia DaidoneGianni Bonadonna Report Pages: 161 - 169
Cell kinetics of histologic variants ofin situ breast carcinoma John S. Meyer Report Pages: 171 - 180
Correlation of Fcγ receptors on peripheral blood mononuclear cells and survival in patients with metastatic breast cancer David IlfeldJoshua BarzilayMaya Ran Report Pages: 181 - 186
Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicity David R. StrayerWilliam A. CarterIsadore Brodsky Report Pages: 187 - 192
Menopausal estrogen use and the risk of breast cancer Jill A. McDonaldNoel S. WeissLincoln Polissar Report Pages: 193 - 199
Immunological detection and quantitation of alpha transforming growth factors in human breast carcinoma cells Isabelle PerroteauDavid SalomonJames Tam Report Pages: 201 - 210
Aminoglutethimide-induced myelosuppression J. T. M. van der HeijdenT. A. W. Splinter Correspondence Pages: 211 - 212